Evidence map›Paper›PMID 25623334›Full record

ArticleNeurobiology of aging2015

PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice.

He Wu, Tao Wu, Wei Hua, Xianghui Dong, Yufeng Gao, Xiaochun Zhao, Wenwu Chen, Wangsen Cao, Qingwu Yang, Jiping Qi and 2 more

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. 20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Neuroprotection of brain-permeable iron chelator VK-28 against intracerebral hemorrhage in mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

He WuDepartment of Pathology, First Clinical Hospital, Harbin Medical University, Harbin, China; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Tao WuDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Stroke Center, Stroke Screening and Intervention Base, Changhai Hospital, Second Military Medical University, Shanghai, China.
Wei HuaDepartment of Pathology, First Clinical Hospital, Harbin Medical University, Harbin, China.
Xianghui DongDepartment of Pathology, First Clinical Hospital, Harbin Medical University, Harbin, China.
Yufeng GaoDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Xiaochun ZhaoDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Wenwu ChenDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Wangsen CaoDepartment of Basic Medical Science, Nanjing University School of Medicine, Nanning, China.
Qingwu YangDepartment of Neurology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Jiping QiDepartment of Pathology, First Clinical Hospital, Harbin Medical University, Harbin, China. Electronic address: qijiping2003@163.com.
Jin ZhouDepartment of Hematology, First Clinical Hospital, Harbin Medical University, Harbin, China. Electronic address: zhoujin1960@hotmail.com.
Jian WangDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. Electronic address: jwang79@jhmi.edu.
Johns Hopkins Medicine · USFirst Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNJohns Hopkins University · USChanghai Hospital · CNNanjing University · CNXinqiao Hospital · CN

Funding

Neuroprotective effect of flavanol (-) epicatechin after intracerebral hemorrhageR01AT007317 · NCCIH · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2012 to 2016
$2.0M
PGE2 EP1 and EP3 receptors as therapeutic targets in intracerebral hemorrhageR01NS078026 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2012 to 2016
$1.8M
Role of PGE2 receptors in the aging brain after intracerebral hemorrhageK01AG031926 · NIA · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2008 to 2012
$536k
NCCIH NIH HHS R01 AT007317NCCIH NIH HHS R01AT007317NIA NIH HHS K01 AG031926NIA NIH HHS K01AG031926NINDS NIH HHS R01 NS078026NINDS NIH HHS R01NS078026
6 · The paper itself

Abstract

Intracerebral hemorrhage (ICH) is a devastating form of stroke. Misoprostol, a synthetic prostaglandin E1 (PGE1) analog and PGE2 receptor agonist, has shown protection against cerebral ischemia. In this study, we tested the efficacy of misoprostol in the 12-month-old mice subjected to 1 of 2 complementary ICH models, the collagenase model (primary study) and blood model (secondary study, performed in an independent laboratory). We also investigated its potential mechanism of action. Misoprostol posttreatment decreased brain lesion volume, edema, and brain atrophy and improved long-term functional outcomes. In the collagenase-induced ICH model, misoprostol decreased cellular inflammatory response; attenuated oxidative brain damage and gelatinolytic activity; and decreased high-mobility group box 1 (HMGB1) expression, Src kinase activity, and interleukin-1β expression without affecting cyclooxygenase-2 expression. Furthermore, HMGB1 inhibition with glycyrrhizin decreased Src kinase activity, gelatinolytic activity, neuronal death, and brain lesion volume. Src kinase inhibition with 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) decreased gelatinolytic activity and brain edema and improved neurologic function but did not decrease HMGB1 protein level. These results indicate that misoprostol protects brain against ICH injury through mechanisms that may involve the HMGB1, Src kinase, and matrix metalloproteinase-2/9 pathways.

Indexed as

Neuroprotective AgentsAnimalsCerebral HemorrhageDisease Models, AnimalFibroblast Growth Factor 1Gene ExpressionGlycyrrhizic AcidInflammationInterleukin-1betaMaleMatrix Metalloproteinase 2Mice, Inbred C57BLMisoprostolReceptors, Prostaglandin Esrc-Family KinasesFibroblast Growth Factor 1Glycyrrhizic AcidInterleukin-1betaMatrix Metalloproteinase 2MisoprostolNeuroprotective AgentsReceptors, Prostaglandin Esrc-Family KinasesGlycyrrhizinHigh-mobility group box 1InflammationMatrix metalloproteinasePGE(2)Src

Identifiers

PMID25623334
PMCPMC4417504
OpenAlexW1975895958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.